DXCM vs SPIR · P/E 63, rev $4.03B vs rev $110.5M
DexCom Inc (DXCM) versus Spire Global Inc (SPIR) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Spire Global Inc (SPIR) is a specialty business services company listed on US.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported SPIR revenue for 2024-12-31 was $110.5M. Net income was -$102.8M. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. SPIR currently screens at market cap $351.2M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. SPIR currently screens at market cap $351.2M.
Not investment advice. Open the DXCM and SPIR stock pages for the full models.
Not investment advice.